| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | 0.0041 | 0.9 |
| mRNA | PFI-1 | GDSC1000 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.004 | 0.9 |
| mRNA | A-770041 | GDSC1000 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | BRD-K48477130 | CTRPv2 | pan-cancer | AAC | -0.0056 | 0.9 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.0055 | 0.9 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | BRD-K29086754 | CTRPv2 | pan-cancer | AAC | 0.0072 | 0.9 |
| mRNA | SN-38 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |